NCT06489704View on ClinicalTrials.gov

High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
High Altitude Pulmonary Hypertension
Interventions
OTHER

Echocardiography

Echocardiography will be performed according to clinical standards

Trial Locations (1)

Unknown

Aksay Medical Center, Aksay Plateau, Naryn, Kyrgyzstan, Kyrgyzstan

All Listed Sponsors
lead

University of Zurich

OTHER

NCT06489704 - High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m) | Biotech Hunter | Biotech Hunter